The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Clinical management of metastatic colorectal cancer in the era of precision medicine
Open accessAbstract
Colorectal cancer (CRC) represents approximately 10% of all cancers and is the second most common cause of cancer deaths. Initial clinical presentation as metastatic CRC (mCRC) occurs in approximately 20% of patients. Moreover, up to 50% of patients with localized disease eventually develop metastases. Appropriate clinical management of these patients is still a challenging medical issue. Major efforts have been made to unveil the molecular landscape of mCRC. This has resulted in the identification of several druggable tumor molecular targets with the aim of developing personalized treatments for each patient. This review summarizes the improvements in the clinical management of patients with mCRC in the emerging era of precision medicine. In fact, molecular stratification, on which the current treatment algorithm for mCRC is based, although it does not completely represent the complexity of this disease, has been the first significant step toward clinically informative genetic profiling for implementing more effective therapeutic approaches. This has resulted in a clinically relevant increase in mCRC disease control and patient survival. The next steps in the clinical management of mCRC will be to integrate the comprehensive knowledge of tumor gene alterations, of tumor and microenvironment gene and protein expression profiling, of host immune competence as well as the application of the resulting dynamic changes to a precision medicine‐based continuum of care for each patient. This approach could result in the identification of individual prognostic and predictive parameters, which could help the clinician in choosing the most appropriate therapeutic program(s) throughout the entire disease journey for each patient with mCRC. CA Cancer J Clin. 2022;72:000‐000.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–216 of 216
Characterizing MRI features of rectal cancers with different KRAS status
Xu, Y., Xu, Q., Ma, Y., Duan, J., Zhang, H., Liu, T., Li, L., Sun, H., Shi, K., Xie, S., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6341-6 · Cited by 31
Cremolini, C., Rossini, D., Antoniotti, C., Pietrantonio, F., Lonardi, S., Salvatore, L., Marmorino, F., Borelli, B., Ambrosini, M., Barsotti, G., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.08.2094 · Cited by 30
Rossini, D., Germani, M. M., Pagani, F., Pellino, A., Dell’Aquila, E., Bensi, M., Liscia, N., Moretto, R., Boccaccino, A., Prisciandaro, M., et al. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.03.009 · Cited by 27
Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data
Sardo, E., Napolitano, S., Corte, C. M. D., Ciardiello, D., Raucci, A., Arrichiello, G., Troiani, T., Ciardiello, F., Martinelli, E., & Martini, G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020128 · Cited by 27
Self-citationVitale, P., Zanaletti, N., Famiglietti, V., Falco, V. D., Cervantes, A. M. R., Roselló, S., Fenocchio, E., Milanesio, M. C., Lombardi, P., Ciardiello, D., et al. (2021) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2021.06.002 · Cited by 23
Self-citationKopetz, S., Grothey, A. F., Yaeger, R. D., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.tps3619 · Cited by 23
Ros, J., Baraibar, I., Martini, G., Salvà, F., Gonzalez, N. S., Cuadra‐Urteaga, J. L., Dienstmann, R., Tabernero, J. M., & Élez, E. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00913-5 · Cited by 22
Self-citationImmunotherapy in colorectal cancer: is the long-awaited revolution finally happening?
Arrichiello, G., Poliero, L., Borrelli, C., Paragliola, F., Nacca, V., Napolitano, S., Corte, C. M. D., Martini, G., & Martinelli, E. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100442 · Cited by 21
Self-citationThe Prognostic Value of 18F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
Arslan, E., Aksoy, T., Gürsu, R. U., Dursun, N., Çakar, E., & Çermik, T. F. (2020) · Molecular Imaging and Radionuclide Therapy · doi:10.4274/mirt.galenos.2019.33866 · Cited by 19
Karani, A., Felismino, T. C., Diniz, L. A., de Macêdo, M. P., Silva, V. S. E., & de Mello, C. A. L. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1069 · Cited by 18
Tanioka, H., Asano, M., Yoshida, R., Waki, N., Uno, F., Ishizaki, M., Yamashita, K., Morishita, Y., & Nagasaka, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.9127 · Cited by 17
Ciardiello, D., Blauensteiner, B., Matrone, N., Belli, V., Mohr, T. T., Vitiello, P. P., Martini, G., Poliero, L., Cardone, C., Napolitano, S., et al. (2021) · Medical Oncology · doi:10.1007/s12032-021-01464-3 · Cited by 16
Self-citationPietrantonio, F., Morano, F., Lonardi, S., Raimondi, A., Salvatore, L., Marmorino, F., Murgioni, S., Pella, N., Antonuzzo, L., Ritorto, G., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.08.905 · Cited by 16
Chong, L. C., Hardingham, J. E., Townsend, A. R., Piantadosi, C., Rico, G. T., Karapetis, C. S., Padbury, R., Maddern, G. J., Roy, A. C., & Price, T. J. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00760-8 · Cited by 12
Ciardiello, D., Famiglietti, V., Napolitano, S., Esposito, L., Normanno, N., Avallone, A., Latiano, T. P., Maiello, E., Pietrantonio, F., Cremolini, C., et al. (2021) · Cancers · doi:10.3390/cancers13225715 · Cited by 11
Self-citationAdagrasib Data Create Buzz at ESMO
(2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-nb2021-0385 · Cited by 3
Cited by
Napolitano, S., Martini, G., Ciardiello, D., Di Maio, M., Normanno, N., Avallone, A., Martinelli, E., Maiello, E., Troiani, T., & Ciardiello, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.940523 · Cited by 35
Self-citationPostwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023) · Medical Oncology · doi:10.1007/s12032-023-02201-8 · Cited by 26
Itraconazole inhibits tumor growth via CEBPB‐mediated glycolysis in colorectal cancer
Zhang, Y., Li, L., Chu, F., Wu, H., Xiao, X., Ye, J., & Li, K. (2024) · Cancer Science · doi:10.1111/cas.16082 · Cited by 19
Huang, F., Yang, H., Bao, W., Bin, Y., Zhou, S., Wang, M., & Lv, X. (2023) · Clinical and Translational Oncology · doi:10.1007/s12094-023-03268-5 · Cited by 6
Use of Artificial Intelligence in the Diagnosis of Colorectal Cancer
Nduma, B. N., Nkeonye, S., Uwawah, T. D., Kaur, D., Ekhator, C., & Ambe, S. (2024) · Cureus · doi:10.7759/cureus.53024 · Cited by 6
Metadata
- Authors
- Ciardiello, F., Ciardiello, D., Martini, G., Napolitano, S., Tabernero, J., & Cervantes, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2022-04-26
- Volume
- 72
- Issue
- 4
- Pages
- 372-401
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W4224880107
- Cited by
- 528
- References
- 216
- FWCI
- 44.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.